Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: a 6 Months Prospective Study

• Egile Nagusiak: Peter P. eToth (Egilea), Angelo Maria ePatti (Egilea), Dragana eNikolic (Egilea), Rosaria Vincenza eGiglio (Egilea), Giuseppa eCastellino (Egilea), Teresa eBiancucci (Egilea), Fabiana eGeraci (Egilea), Sabrina eDavid (Egilea), Giuseppe eMontalto (Egilea), Ali eRizvi (Egilea), Manfredi eRizzo (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2016-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches for the treatment of dyslipidemia. This has led to a search for alternative therapeutic approaches for dyslipidemia management. In recent studies Citrus bergamia (known as Bergamot) juice was able to...